|
|
Other links at Articles > Hematology-Oncology |
| 5. |
EGFR Inhibitors in Non-Small-Cell Lung Cancer
|
|
|
In this clinical update, Dr. Roy Herbst explores the significance of EGFR in NSCLC and discusses the latest data on agents that target this receptor pathway. Medscape Hematology-Oncology
|
|
|